Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110427987 | 11042798 | 7 | F | 201312 | 20160722 | 20150417 | 20160729 | EXP | BR-ROCHE-1429388 | ROCHE | 58.77 | YR | F | Y | 47.00000 | KG | 20160729 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110427987 | 11042798 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | SOLUTION FOR INFUSION | |||||||||
| 110427987 | 11042798 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 0 | |||||||||||
| 110427987 | 11042798 | 3 | C | DRAMAMINE | DIMENHYDRINATE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 110427987 | 11042798 | 4 | C | DEFLAZACORT | DEFLAZACORT | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 5 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 6 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 7 | C | MOTILIUM | DOMPERIDONE | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 8 | C | MAALOX (ALUMINUM HYDROXIDE/MAGNESIUM HYDROXIDE) | 2 | 0 | |||||||||||||
| 110427987 | 11042798 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 10 | C | MESALAZINE | MESALAMINE | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 11 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 12 | C | SELOZOK | METOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
| 110427987 | 11042798 | 13 | C | MAREVAN | WARFARIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110427987 | 11042798 | 1 | Rheumatoid arthritis |
| 110427987 | 11042798 | 2 | Product used for unknown indication |
| 110427987 | 11042798 | 4 | Rheumatoid arthritis |
| 110427987 | 11042798 | 5 | Hypertension |
| 110427987 | 11042798 | 6 | Hypertension |
| 110427987 | 11042798 | 11 | Pulmonary oedema |
| 110427987 | 11042798 | 13 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110427987 | 11042798 | OT |
| 110427987 | 11042798 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110427987 | 11042798 | Blood cholesterol increased | |
| 110427987 | 11042798 | Blood triglycerides abnormal | |
| 110427987 | 11042798 | Cardiac failure | |
| 110427987 | 11042798 | Colitis | |
| 110427987 | 11042798 | Colitis ischaemic | |
| 110427987 | 11042798 | Dizziness | |
| 110427987 | 11042798 | Dyspnoea | |
| 110427987 | 11042798 | Enterocolitis haemorrhagic | |
| 110427987 | 11042798 | Fatigue | |
| 110427987 | 11042798 | Gastrointestinal inflammation | |
| 110427987 | 11042798 | Headache | |
| 110427987 | 11042798 | Hyponatraemia | |
| 110427987 | 11042798 | Ischaemia | |
| 110427987 | 11042798 | Low density lipoprotein increased | |
| 110427987 | 11042798 | Nasopharyngitis | |
| 110427987 | 11042798 | Oropharyngeal pain | |
| 110427987 | 11042798 | Pain in extremity | |
| 110427987 | 11042798 | Pulmonary embolism | |
| 110427987 | 11042798 | Sciatica | |
| 110427987 | 11042798 | Very low density lipoprotein increased | |
| 110427987 | 11042798 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110427987 | 11042798 | 1 | 20130101 | 0 | ||
| 110427987 | 11042798 | 2 | 201405 | 0 |